Chronic kidney disease, cardiovascular risk, and response to angiotensin-converting enzyme inhibition after myocardial infarction: the Survival And Ventricular Enlargement (SAVE) study.
about
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney diseaseHeart failure in patients with chronic kidney disease: a systematic integrative reviewLaboratory markers of ventricular arrhythmia risk in renal failureCardiac assessment for renal transplantationImproved survival with bisoprolol in patients with heart failure and renal impairment: an analysis of the cardiac insufficiency bisoprolol study II (CIBIS-II) trialAngiotensin-converting enzyme inhibitor, angiotensin receptor blocker use, and mortality in patients with chronic kidney disease.Renal impairment and heart failure with preserved ejection fraction early post-myocardial infarctionResponse to Sexton: Inhibiting the renin-angiotensin-aldosterone system in patients with heart failure and renal dysfunction: common sense or nonsense?Renal function at the time of a myocardial infarction maintains prognostic value for more than 10 yearsPotential role of differential medication use in explaining excess risk of cardiovascular events and death associated with chronic kidney disease: a cohort studyLow glomerular filtration rate, recurrent stroke risk, and effect of renin-angiotensin system modulation.Fibroblast growth factor-23, cardiovascular prognosis, and benefit of angiotensin-converting enzyme inhibition in stable ischemic heart diseaseThe impact of intravenous ferric carboxymaltose on renal function: an analysis of the FAIR-HF study.Hospital performance and differences by kidney function in the use of recommended therapies after non-ST-elevation acute coronary syndromes.Comorbidity in patients undergoing coronary artery bypass graft surgery: impact on outcome and implications for cardiac rehabilitation.Kidney function and risk of cardiovascular disease and mortality in women: a prospective cohort study.Echocardiographic markers of left ventricular dysfunction among men with uncontrolled hypertension and stage 3 chronic kidney diseaseAcute decline in renal function, inflammation, and cardiovascular risk after an acute coronary syndrome.Atherosclerosis in chronic kidney disease: the role of macrophagesCardio-renal syndromes: from foggy bottoms to sunny hills.Targeting the renin angiotensin system in dialysis patients.Chronic kidney disease and vascular remodelling: molecular mechanisms and clinical implications.Worsening renal function during renin-angiotensin-aldosterone system inhibitor initiation and long-term outcomes in patients with left ventricular systolic dysfunction.Calibrating the impact of dual RAAS blockade on the heart and the kidney - balancing risks and benefits.Designing a comprehensive strategy to improve one core measure: discharge of patients with myocardial infarction or heart failure on ACE inhibitors/ARBs.Angiotensin-converting enzyme inhibitor/angiotensin receptor blocker use and cardiovascular outcomes in patients initiating peritoneal dialysis.Angiotensin receptor blocker-based therapy and cardiovascular events in hypertensive patients with coronary artery disease and impaired renal function.Does estimated glomerular filtration rate have an effect on left ventricular function after ST-elevation myocardial infarction?Beta-blockers for coronary heart disease in chronic kidney disease.Treatment effects of renin-angiotensin aldosterone system blockade on kidney failure and mortality in chronic kidney disease patients.Heart Failure and Kidney Disease.Chronic kidney disease and cognitive impairment among the very old in China.Benefit of Ezetimibe Added to Simvastatin in Reduced Kidney Function.Kidney Function, ACE-Inhibitor/Angiotensin Receptor Blocker Use, and Survival Following Hospitalization for Heart Failure: A Cohort Study
P2860
Q24235834-1A167AE6-BE50-4393-97D9-DB21DBB0086BQ26824149-D8C08DFB-9905-4215-8099-13B03AFEDF4BQ27004652-BBEE9C65-8549-4B58-9777-A8A8C9B833C6Q28195710-5B91E8C8-566D-4AE4-886A-610950C82082Q28278243-6038C5A8-A3C9-4F05-892B-48953BFF7A35Q30407860-77C74609-E18D-470C-A7C5-2670E46D84AEQ30434062-AC56B0D7-1D3B-4075-A078-990D70F9DFE3Q33652436-A114E95B-3819-406E-97EB-CB576D482B14Q33943876-30FAD718-2553-4213-A7C3-67EAAEA10993Q34019491-8235AF45-310E-433D-8F26-17E59780BD3CQ34053329-09CA50DE-9C8A-4AB1-8C6B-37DFDFE5F6D9Q34421217-1D27B1FB-739E-452C-AE43-325032B04D5DQ35549440-E23D786A-295C-454E-B953-C7DEEE7F707BQ37151458-76DA4232-DF4B-4BB4-BFFC-90DF2EF83A59Q37234346-46C905CD-1A9F-43C9-9A76-6BEF7E4244CCQ37248468-32B8B554-9CA0-4343-8B80-AE992F86DBF3Q37255160-54E817F3-0BA4-4661-9B6F-A6B7D6EAC539Q37415740-52C16CAF-EFF5-4F57-956A-9912605A8F27Q37811885-F86C46E6-CEFA-49B0-BAF6-2F945146EE56Q37831837-5769B62E-BA1C-4F16-B4FA-41BB98F3F5C3Q37891151-2B5A7F9E-B172-4685-899F-7C0C86C080EAQ38016491-076836A5-48C2-495F-AED9-2ACEC40DB0D0Q38181037-251B5872-8DF9-43D9-A2C4-782F522B9ADCQ38859432-94A8816C-D149-436D-8E0E-6AC689835EA0Q39650986-C9006D14-CA0C-40AB-9EDC-3742FE0B7D8FQ39758052-D21614BD-BA57-468B-826F-98D147762A4DQ43057341-7991AC19-272B-4C3F-94B7-F90B08A0F9E8Q45906134-46776A4C-46C4-40CA-8453-E567F8601AFBQ46813830-985F9DD1-84D5-452F-A65E-9BA7D0900ABDQ47153972-C2222E39-6E91-45C2-85CB-2722E5A7E778Q47437642-9609C6D5-B185-484A-BE25-A14560B77620Q50574647-86749F6E-AD36-475D-B77F-F62BE7921F4EQ53494879-E1ECF39E-0E4B-4E4D-85C6-BA1A0B7A9D86Q57814734-DA044ED7-0152-4A74-89A7-4BC367BE002D
P2860
Chronic kidney disease, cardiovascular risk, and response to angiotensin-converting enzyme inhibition after myocardial infarction: the Survival And Ventricular Enlargement (SAVE) study.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Chronic kidney disease, cardio ...... ular Enlargement (SAVE) study.
@en
type
label
Chronic kidney disease, cardio ...... ular Enlargement (SAVE) study.
@en
prefLabel
Chronic kidney disease, cardio ...... ular Enlargement (SAVE) study.
@en
P2093
P50
P1433
P1476
Chronic kidney disease, cardio ...... ular Enlargement (SAVE) study.
@en
P2093
Glenn M Chertow
Jean L Rouleau
Lemuel A Moyé
Marc A Pfeffer
Mariya P Tokmakova
Milton Packer
Scott D Solomon
P304
P356
10.1161/01.CIR.0000149806.01354.BF
P407
P577
2004-11-29T00:00:00Z